Wave Life Sciences (WVE) Operating Income (2014 - 2026)
Wave Life Sciences (WVE) posted Operating Income of -$31.3 million for Q1 2026, up 44.57% on a QoQ basis from -$56.5 million in Q4 2025, and up 37.16% year-over-year from -$22.8 million in Q1 2025.
Wave Life Sciences (WVE) Operating Income (2014 - 2026) Analysis & Trends
Wave Life Sciences' Operating Income history runs 13 years deep, the most recent figure standing at -$31.3 million for Q1 2026.
- Quarterly Operating Income rose 37.16% year-over-year to -$31.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$196.9 million (down 56.56% YoY) and the FY2025 annual result came in at -$215.4 million, down 95.09% from the prior year.
- Operating Income was -$31.3 million for Q1 2026 at Wave Life Sciences, up from -$56.5 million in the prior quarter.
- Across five years, Operating Income topped out at $23.0 million in Q4 2024 and bottomed at -$63.9 million in Q3 2024.
- A 5-year average of -$34.6 million and a median of -$38.1 million in 2022 frame the typical range for Operating Income.
- Peak annual rise in Operating Income reached 222.94% in 2024, while the deepest fall reached 1538.23% in 2024.
- Wave Life Sciences' Operating Income stood at -$43.6 million in 2022, then soared by 57.11% to -$18.7 million in 2023, then soared by 222.94% to $23.0 million in 2024, then plunged by 345.86% to -$56.5 million in 2025, then surged by 44.57% to -$31.3 million in 2026.
- Business Quant data shows WVE's Operating Income at -$31.3 million in Q1 2026, -$56.5 million in Q4 2025, and -$56.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -31.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.30 Mn |
| Dec 31, 2025 | -56.47 Mn |
| Sep 30, 2025 | -56.35 Mn |
| Jun 30, 2025 | -52.76 Mn |
| Mar 31, 2025 | -49.80 Mn |
| Dec 31, 2024 | 22.97 Mn |
| Sep 30, 2024 | -63.92 Mn |
| Jun 30, 2024 | -35.00 Mn |
| Mar 31, 2024 | -34.46 Mn |
| Dec 31, 2023 | -18.68 Mn |
| Sep 30, 2023 | 4.44 Mn |
| Jun 30, 2023 | -23.47 Mn |
| Mar 31, 2023 | -30.29 Mn |
| Dec 31, 2022 | -43.56 Mn |
| Sep 30, 2022 | -38.90 Mn |
| Jun 30, 2022 | -42.16 Mn |
| Mar 31, 2022 | -38.09 Mn |
| Dec 31, 2021 | -36.11 Mn |
| Sep 30, 2021 | -7.61 Mn |
| Jun 30, 2021 | -39.83 Mn |